Weight Loss Peptides Australia

The most researched weight loss peptides include Retatrutide (triple GLP-1/GIP/glucagon agonist), Tirzepatide (dual GLP-1/GIP agonist), Cagrilintide (amylin analogue for appetite control), 5-Amino-1MQ (NNMT inhibitor for metabolic boosting), and Tesamorelin (GHRH analog for body recomposition). Each works through different pathways – appetite suppression, metabolic shifting, or hormonal modulation – allowing researchers to select the most appropriate compound for their study design.

Retatrutide is a triple agonist that simultaneously activates GLP-1, GIP, and glucagon receptors. GLP-1 activation suppresses appetite and delays gastric emptying. GIP activation enhances insulin sensitivity and metabolic efficiency. Glucagon activation increases energy expenditure. Together these three pathways create a comprehensive approach to metabolic regulation that research suggests outperforms single-agonist compounds.

Tirzepatide is a dual agonist targeting GLP-1 and GIP receptors. It is extensively researched for appetite suppression and glucose control. Retatrutide adds a third pathway – glucagon receptor activation – which increases energy expenditure on top of the appetite and glucose effects. Research suggests Retatrutide may produce superior fat loss outcomes due to this additional metabolic-boosting mechanism.

5-Amino-1MQ works by inhibiting NNMT (Nicotinamide N-methyltransferase), an enzyme that increases with age and promotes fat storage. By blocking NNMT, research suggests it elevates NAD+ levels specifically in fat cells, shifting metabolism from energy storage to energy burning mode. Unlike appetite suppressants, 5-Amino-1MQ targets the cellular machinery of fat metabolism directly.

The Retatrutide Starter Bundle is an all-in-one research kit containing: Retatrutide (choice of 2 x 10mg vials or 1 x 20mg vial), bacteriostatic water for reconstitution, syringes for precise measurement, and alcohol swabs for sterile handling. It provides everything needed to begin peptide preparation protocols in one convenient package.

In Australia, bioactive peptides including GLP-1 agonists are regulated under the Poisons Standard. OzPep supplies all peptides strictly for in-vitro research and laboratory use only. They are not intended for human consumption, therapeutic use, or any application outside approved research. Researchers must hold appropriate licenses and comply with TGA regulations and state laws.

Lyophilised peptides should be stored at -20°C, protected from light and moisture. Once reconstituted with bacteriostatic water, refrigerate at 2-8°C and use within 30 days. GLP-1 agonists like Retatrutide and Tirzepatide are particularly sensitive to temperature fluctuations. Never freeze reconstituted solutions. Always handle with sterile technique in a laboratory environment.

NAD+ (Nicotinamide Adenine Dinucleotide) is an essential coenzyme for cellular energy production and mitochondrial function. In weight loss research, NAD+ is studied for its role in metabolic regulation, sirtuin activation, and cellular repair processes. Higher NAD+ levels are associated with increased metabolic activity and improved energy utilisation. It works synergistically with NNMT inhibitors like 5-Amino-1MQ.

Tesamorelin is a GHRH analog that stimulates the pituitary to release growth hormone. Elevated GH increases lipolysis (fat breakdown) and helps preserve lean muscle mass during caloric restriction. Unlike direct fat burners, Tesamorelin works through the endocrine system to research body recomposition – the simultaneous reduction of adipose tissue and maintenance of muscle tissue.

Yes, OzPep ships to all Australian states and territories from our Melbourne warehouse. Express shipping with tracking is available on all orders. Free shipping applies to orders over $200. All peptides are dispatched in temperature-safe packaging to protect integrity during transit. Delivery typically takes 1-5 business days. Every order is backed by our quality guarantee and independent COA verification.